SCHEMBL1156928

SCHEMBL1156928

O/N=N/O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13555402 1.00
Methane SCHEMBL397821 0.91 CA1 (0.33)
SCHEMBL2304709 0.91
Ammonia Solution, Strong SCHEMBL4116846 0.91
Methane SCHEMBL818106 0.84 CA1 (0.30)
Formaldehyde SCHEMBL15406088 0.79
Nitrous Acid SCHEMBL7205839 0.79
SCHEMBL3392178 0.74
SCHEMBL15811753 0.71
SCHEMBL13250831 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4301340-A1 MICELLE RELEASING THERMOSENSITIVE HYDROGELS AS A THERAPEUTIC DELIVERY SYSTEM Georgia Tech Research Corporation (US) 2024-01-10 EP claimed
CN-115501204-B Preparation method of hyaluronic acid nano drug delivery system for cascade drug delivery 河北工业大学 2023-07-21 CN claimed
CN-115501204-A Preparation method of hyaluronic acid nano drug delivery system for cascade drug delivery 河北工业大学 2022-12-23 CN claimed
EP-1439187-B1 O2-ARYLATED OR O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O2-SUBSTITUTED 1- (2-CARBOXYLATO)PYRROLIDIN-1-YL DIAZEN-1-IUM-1,2-DIOLATES US HEALTH (US) 2013-12-18 EP claimed
EP-2632255-A1 DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES Merck Sharp & Dohme Corp. (US) 2013-09-04 EP claimed
WO-2012058203-A1 DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-05-03 WO claimed
US-20080288176-A1 Development of Prodrugs Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Noiety Using in Vitro/in Silico Predictions TAM YUN KAU 2008-11-20 US claimed
WO-2025230641-A1 NITRIC OXIDE-RELEASING LIPOSOMES AS THERAPY FOR RESPIRATORY INFECTIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2025-11-06 WO disclosed
EP-3936608-B1 REPROGRAMMING CELLS SCRIPPS RESEARCH INST (US) 2025-05-07 EP disclosed
US-20240139104-A1 MICELLE RELEASING THERMOSENSITIVE HYDROGELS AS A THERAPEUTIC DELIVERY SYSTEM GEORGIA TECH RESEARCH CORPORATION 2024-05-02 US disclosed
US-11807529-B1 Photosensitized release of nitric oxide UNIVERSITY OF PUERTO RICO (US) 2023-11-07 US disclosed
CN-115501204-B Preparation method of hyaluronic acid nano drug delivery system for cascade drug delivery 河北工业大学 2023-07-21 CN disclosed
CN-110198959-B Nitric oxide releasing alginate as biodegradable antimicrobial scaffolds and related methods 北卡罗米纳大学查佩尔希尔分校 2023-03-28 CN disclosed
WO-2003056899-A9 NITRIC OXIDE DONORS FOR TREATMENT OF DISEASE AND INJURY FORD HENRY HEALTH SYSTEM (US) 2004-04-15 WO disclosed
WO-2003095398-A2 POLYDIAZENIUMDIOLATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND METHODS OF USING SAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-11-20 WO disclosed
WO-2003056899-A2 NITRIC OXIDE DONORS FOR TREATMENT OF DISEASE AND INJURY HENRY FORD HEALTH SYSTEM (US) 2003-07-17 WO disclosed
US-20020004498-A1 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction DOHERTY PAUL C (US) 2002-01-10 US disclosed
US-20010046471-A1 Infrared thermograpy and methods of use NICOX S.A. (FR) 2001-11-29 US disclosed
US-6147068-A RELEASING NITRIC OXIDE THE UNIVERSITY OF AKRON (US) 2000-11-14 US disclosed
WO-1999065563-A1 ELECTRICALLY ASSISTED TRANSDERMAL METHOD AND APPARATUS FOR THE TREATMENT OF ERECTILE DYSFUNCTION GENETRONICS, INC. (US) 1999-12-23 WO disclosed